Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Expert Panel to Discuss the National Opioid Emergency and Need for Medication Assisted Treatment

Advocates for Opioid Recovery
Posted on: 07 Nov 17

President Trump declared the opioid epidemic a national public health emergency, with more than 175 American lives lost daily to opioid overdose. Fewer than 3 percent of Americans living with opioid addiction receive medication assisted treatment (MAT), the most effective long-term recovery solution. With recent release of the President’s Commission on Combating Drug Addiction and the Opioid Crisis’ final report, now is the time to lower the barriers to effective, lifesaving treatments.

This event will discuss the role of MAT in addressing the opioid crisis, the White House Opioid Commission’s related recommendations, and Congress’ role in making MAT the most common practice for opioid addiction treatment, particularly in Medicare and other government sponsored healthcare plans.


  • Former Congressman Patrick J. Kennedy, AOR Advisor, Member of the President’s Commission on Combating Drug Addiction and the Opioid Crisis
  • Former Congresswoman Mary Bono, Co-Founder, Collaborative for Effective Prescription Opioid Policies (CEPOP)
  • Mark Parrino, President, American Association for the Treatment of Opioid Dependence, Inc. (AATOD)
  • Dr. Frances Levin, Past President of American Academy of Addiction Psychiatry; Kennedy-Leavy Professor of Clinical Psychiatry at Columbia University; Chief of Substance Abuse Division at NY Presbyterian Hospital
  • ModeratorBrianna Ehley, POLITICO Healthcare Reporter


      Wednesday, November 15, 2017


4:00PM-5:30PM EST


U.S. Capitol Visitor Center
First Street NE, HVC 200
Washington, DC 20515


Registration Link


Advocates for Opioid Recovery is dedicated to advancing a science-based, evidence-based treatment system that can reduce death and suffering from opioid addiction, and produce more long-term opioid addiction survivors who are positively engaged with their families and communities.To learn more about AOR, visit

Collaborative for Effective Prescription Opioid Policies engages diverse stakeholders behind a comprehensive and balanced public policy strategy to reduce prescription opioid abuse and promote treatment options, both for those living with chronic pain and confronting addiction. We are growing rapidly with involvement from patient and family advocacy, provider, public health, dispensing, distribution, and manufacturing organizations. To learn more about CEPOP, visit

View source version on

Business Wire

Last updated on: 14/11/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.